A Study of Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer.

NCT00531934 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Doxycline
DRUG: erlotinib [Tarceva]

Sponsor

Hoffmann-La Roche